About Auxilium Pharmaceuticals
Auxilium Pharmaceuticals is a Healthcare company based in Philadelphia (United States) founded in 1999, and was acquired by Endo International in October 2014. Developer of therapeutics and drug-device combinations for urology and sexual health. Auxilium Pharmaceuticals has raised $43 million across 1 funding round from investors including Credit Suisse, Endo International and Schroders. Auxilium Pharmaceuticals has completed 1 acquisition, including Actient Pharma. Its focus areas include Life Sciences, Women Health, Drugs and Sustainability Tech. Its competitors include Agile Therapeutics, Xanodyne Pharmaceuticals and Microchips Biotech; 3 of its 3 listed competitors have raised funding.
Company details
Auxilium Pharmaceuticals was founded in 1999 and is based in Philadelphia, United States. Therapeutics and drug-device combinations are developed by the company for urology and sexual health, including treatments for hypogonadism (Testim), testosterone replacement (Testopel, Striant), and erectile dysfunction (Edex, Osbon ErecAid, Stendra). Additional development efforts have been directed toward therapies for respiratory diseases and rare disorders within the pharmaceutical sector.
- Headquarters Philadelphia, United States
- Stage Acquired
- SectorsHealthcare
- Website auxilium.com
- Social LinkedIn
- Acquired by Endo International (Oct 2014)
- Total Equity Funding$43M (USD)
in 1 rounds
- Latest Funding Round$43M (USD), Series D
Nov 2003
- InvestorsCredit Suisse
& 6 more
- Investments & Acquisitions
- Acquired byEndo International
(Oct 2014)
Funding Insights of Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has successfully raised a total of $43M through 1 strategic funding round. The most recent funding activity was a Series D round of $43 million completed in November 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $43M
- Total Rounds 1
- Last Round Series D β $43M
- First Round $43M
(Nov 2003)
- Investors Count 6
All 1 funding rounds of Auxilium Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2003 | $43M | Series D | β | β |
7 investors in total: 7 institutional.
Investors in Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Endo International and Schroders.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
| bbbiotechventures.com | ||||
| scppartners.com | ||||
Global financial advisory services are provided by the firm. | lehman.com | New York, United States | ||
Investment management and wealth management services are provided to clients. | 1804 | schroders.com | London, United Kingdom | |
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland | |
Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines | 1997 | endo.com | Malvern, United States |
Investor details for Auxilium Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Actient Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Banned-substance-free sports nutrition supplements are manufactured for athletes and bodybuilders. | actientpharma.com | Chicago, United States | 2009 | Apr 2013 | $585M |
Complete acquisition details for Auxilium Pharmaceuticals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Auxilium Pharmaceuticals
5 dated milestones of Auxilium Pharmaceuticals across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Auxilium Pharmaceuticals is founded.
- Funding First funding round of $43.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Actient Pharma.
- Exit Acquired by Endo International.
Competitors of Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has 3 listed competitors in our database, 3 of them funded. They include Agile Therapeutics, Xanodyne Pharmaceuticals and Microchips Biotech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| agiletherapeutics.com | 1997 | Princeton, United States | $123.06M | Therapeutics for women's healthcare are developed and offered. | ||
| xanodyne.com | 2001 | Florence, United States | $175.78M | 6 | Developer of drugs for women's health and pain management | |
| microchipsbiotech.com | 1999 | Lexington, United States | $118.61M | 10 | Microchip implants for wireless drug delivery are developed. |
Detailed competitors of Auxilium Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Auxilium Pharmaceuticals
Websites that share an audience with Auxilium Pharmaceuticals (auxilium.com).
Websites whose visitors overlap most with Auxilium Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| merck.com | 100% | 656.8K | #78,842 | View details | |
| bms.com | 96% | 809.8K | #67,210 | View details | |
| pfizer.com | 95% | 1.9M | #24,984 | View details | |
| auxilium-inc.com | 76% | 1.1K | #12,796,148 | View details | |
| gsk.com | 69% | 1.3M | #56,834 | View details |
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Auxilium Pharmaceuticals (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Auxilium Pharmaceuticals
Complete news archive for Auxilium Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Auxilium Pharmaceuticals
Auxilium Pharmaceuticals was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Auxilium Pharmaceuticals is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Auxilium Pharmaceuticals is a funded company, having raised a total of $43M across 1 funding round to date. The company's 1st funding round was a Series D of $43M, raised on Nov 2003.
Auxilium Pharmaceuticals was founded in 1999 and is based in Philadelphia, United States. Therapeutics and drug-device combinations are developed by the company for urology and sexual health, including treatments for hypogonadism (Testim), testosterone replacement (Testopel, Striant), and erectile dysfunction (Edex, Osbon ErecAid, Stendra). Additional development efforts have been directed toward therapies for respiratory diseases and rare disorders within the pharmaceutical sector.
Auxilium Pharmaceuticals's top competitors include Agile Therapeutics, Microchips Biotech and Xanodyne Pharmaceuticals.
Auxilium Pharmaceuticals has made 1 acquisition, including Actient Pharma.
Auxilium Pharmaceuticals has 7 investors. Key investors include Credit Suisse, Endo International, Schroders, Orbimed, and BB Biotech Ventures.
Yes. Auxilium Pharmaceuticals was acquired by Endo International in October 2014.

